Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aldo Scarpa

Showing results (471-480 of 574) with videos related to

Pageof 58
Sort By:
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 25, 2015
International Association of Pancreatology (IAP)/European Pancreatic Club (EPC) consensus review of guidelines for the treatment of pancreatic cancerKyoichi Takaori, Claudio Bassi, Andrew Biankin, et al.
Annals of Surgical Oncology|July 2, 2024
Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management ProtocolsOzgur Can Eren, Pelin Bagci, Serdar Balci, et al.
The American Journal of Pathology|September 5, 2012
Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with poorer survivalAlessandra Rosati, Samantha Bersani, Francesca Tavano, et al.
Pancreas|May 18, 2018
Systemic Chemotherapy for Advanced Rare Pancreatic Histotype Tumors: A Retrospective Multicenter AnalysisOronzo Brunetti, Giuseppe Aprile, Paolo Marchetti, et al.
The Journal of Pathology|July 2, 2019
The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapyClaire S Reader, Sabari Vallath, Colin W Steele, et al.
Gut|April 26, 2024
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDACFrancesca Lupo, Francesco Pezzini, Davide Pasini, et al.
Gut|May 27, 2022
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancerMaria Chiara De Santis, Luca Gozzelino, Jean Piero Margaria, et al.
The Journal of Pathology|October 12, 2018
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreasEliana Amato, Andrea Mafficini, Kenichi Hirabayashi, et al.
Endocrine Pathology|July 9, 2026
An Integrative RNA Spliceosomic Landscape of Pancreatic Neuroendocrine Tumors Identifies Clinically Relevant Molecular SubgroupsRicardo Blázquez-Encinas, Víctor García-Vioque, Andrea Mafficini, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 21, 2025
Fatty pancreas disease: an integrated study on frozen tissues shows distinct compartments of inter/intra-lobular, intra-acinar, and intra-islet fat depositionClaudio Luchini, Carlotta Franzina, Federico Caldart, et al.
Pageof 58

Showing results (471-480 of 574) with videos related to

Sort By:
Pageof 58
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 25, 2015
International Association of Pancreatology (IAP)/European Pancreatic Club (EPC) consensus review of guidelines for the treatment of pancreatic cancerKyoichi Takaori, Claudio Bassi, Andrew Biankin, et al.
Annals of Surgical Oncology|July 2, 2024
Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management ProtocolsOzgur Can Eren, Pelin Bagci, Serdar Balci, et al.
The American Journal of Pathology|September 5, 2012
Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with poorer survivalAlessandra Rosati, Samantha Bersani, Francesca Tavano, et al.
Pancreas|May 18, 2018
Systemic Chemotherapy for Advanced Rare Pancreatic Histotype Tumors: A Retrospective Multicenter AnalysisOronzo Brunetti, Giuseppe Aprile, Paolo Marchetti, et al.
The Journal of Pathology|July 2, 2019
The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapyClaire S Reader, Sabari Vallath, Colin W Steele, et al.
Gut|April 26, 2024
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDACFrancesca Lupo, Francesco Pezzini, Davide Pasini, et al.
Gut|May 27, 2022
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancerMaria Chiara De Santis, Luca Gozzelino, Jean Piero Margaria, et al.
The Journal of Pathology|October 12, 2018
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreasEliana Amato, Andrea Mafficini, Kenichi Hirabayashi, et al.
Endocrine Pathology|July 9, 2026
An Integrative RNA Spliceosomic Landscape of Pancreatic Neuroendocrine Tumors Identifies Clinically Relevant Molecular SubgroupsRicardo Blázquez-Encinas, Víctor García-Vioque, Andrea Mafficini, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 21, 2025
Fatty pancreas disease: an integrated study on frozen tissues shows distinct compartments of inter/intra-lobular, intra-acinar, and intra-islet fat depositionClaudio Luchini, Carlotta Franzina, Federico Caldart, et al.
Pageof 58